{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T23:06:59Z","timestamp":1779577619719,"version":"3.53.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejso.2026.111852","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:41:01Z","timestamp":1777545661000},"page":"111852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted axillary dissection in the primary surgery setting for node-positive breast cancer: A systematic review"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6979-7818","authenticated-orcid":false,"given":"James","family":"Lucocq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6357-0053","authenticated-orcid":false,"given":"Sebastian","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejso.2026.111852_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA, J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.ejso.2026.111852_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-021-00276-y","article-title":"The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment","volume":"7","author":"J\u00f8rgensen","year":"2021","journal-title":"NPJ Breast Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2026.111852_bib3","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases","volume":"252","author":"Giuliano","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111852_bib4","series-title":"Consensus statement on axillary management for patients with In-Situ and invasive breast cancer: a concise overview","year":"2022"},{"issue":"13","key":"10.1016\/j.ejso.2026.111852_bib5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","article-title":"Omitting axillary dissection in breast cancer with sentinel-node metastases","volume":"390","author":"de Boniface","year":"2024","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ejso.2026.111852_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.111852_bib7","series-title":"NCCN clinical practice guidelines in oncology (NCCN guidelines\u00ae)","year":"2025"},{"issue":"8","key":"10.1016\/j.ejso.2026.111852_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2023.1772","article-title":"Safety of targeted axillary dissection after neoadjuvant therapy in patients with node-positive breast cancer","volume":"158","author":"Kuemmel","year":"2023","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.ejso.2026.111852_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-024-03413-6","article-title":"Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy","volume":"22","author":"Cab\u0131o\u011flu","year":"2024","journal-title":"World J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2026.111852_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000004572","article-title":"A prospective, multicenter registry study to evaluate the clinical feasibility of Targeted Axillary Dissection (TAD) in node-positive breast cancer patients","volume":"276","author":"Kuemmel","year":"2022","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.ejso.2026.111852_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2025.109689","article-title":"The efficacy and oncological safety of minimally invasive axillary procedures in patients with node-positive breast cancer receiving neoadjuvant chemotherapy: a network meta-regression and trial sequential analysis","volume":"51","author":"Lucocq","year":"2025","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2026.111852_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2018.05.035","article-title":"Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy","volume":"44","author":"Hartmann","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2026.111852_bib13","article-title":"Targeted axillary dissection with 125I seed placement before neoadjuvant chemotherapy in a Danish multicenter cohort","volume":"30","author":"Munck","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2026.111852_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.7073","article-title":"Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer","volume":"97","author":"Straver","year":"2010","journal-title":"Br J Surg"},{"issue":"9","key":"10.1016\/j.ejso.2026.111852_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.10555","article-title":"Combined PET\u2013CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapy","volume":"104","author":"Koolen","year":"2017","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.ejso.2026.111852_bib16","doi-asserted-by":"crossref","DOI":"10.1159\/000517208","article-title":"Targeted axillary dissection after chemotherapy: Feasibility study with clip and carbon dye tattoo - neotarget trial","volume":"17","author":"Pinto","year":"2022","journal-title":"Breast Care"},{"issue":"6","key":"10.1016\/j.ejso.2026.111852_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-095774","article-title":"Consensus process to agree upon surgical quality assurance processes within a pragmatic, multicentre randomised clinical trial comparing targeted axillary dissection and axillary node clearance: the TADPOLE-TOGETHER project","volume":"15","author":"Potter","year":"2025","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.ejso.2026.111852_bib18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10549-024-07328-4","article-title":"Current axillary management of patients with early breast cancer and low-volume nodal disease undergoing primary surgery: results of a United Kingdom national practice survey","volume":"206","author":"Fairhurst","year":"2024","journal-title":"Breast Cancer Res Treat"},{"issue":"16_suppl","key":"10.1016\/j.ejso.2026.111852_bib19","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS628","article-title":"Tailored axillary surgery (TAS) in patients with clinically node-positive breast cancer in the upfront surgery setting: a prospective, single-arm, multicenter trial","volume":"41","author":"Terata","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111852_bib20","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"The BMJ"},{"key":"10.1016\/j.ejso.2026.111852_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS peer review of electronic search strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.ejso.2026.111852_bib22","article-title":"Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. the GRADE approach to developing recommendations","volume":"66","author":"Broazek","year":"2011","journal-title":"Allergy: Eur J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.ejso.2026.111852_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17101682","article-title":"Current indications for seed-marked axillary lymph node dissection in breast cancer","volume":"17","author":"Loayza","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ejso.2026.111852_bib24","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-014-4034-6","article-title":"Initial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patients","volume":"22","author":"Choy","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2026.111852_bib25","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-019-07419-3","article-title":"Pretreatment tattoo marking of suspicious axillary lymph nodes: reliability and correlation with sentinel lymph node","volume":"26","author":"Patel","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111852_bib26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.21037\/gs-22-480","article-title":"Accuracy of sentinel node mapping in patients with biopsy-proven metastatic axillary lymph nodes and upfront surgery: preliminary results of the Multimodal Targeted Axillary Surgery (MUTAS) trial","volume":"12","author":"Vernet-Tom\u00e1s","year":"2023","journal-title":"Gland Surg"},{"issue":"12","key":"10.1016\/j.ejso.2026.111852_bib27","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1097\/MS9.0000000000002616","article-title":"An associate of suspicious axillary node and sentinel node in breast cancer to minimizing axillary surgery, prospective cohort study","volume":"86","author":"Chirappapha","year":"2024","journal-title":"Ann Med Surg"},{"issue":"2","key":"10.1016\/j.ejso.2026.111852_bib28","article-title":"Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients","volume":"166","author":"Ahmed","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.ejso.2026.111852_bib29","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1245\/s10434-010-0945-z","article-title":"Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial","volume":"17","author":"Straver","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111852_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/s12893-023-02101-8","article-title":"Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis","volume":"23","author":"Fan","year":"2023","journal-title":"BMC Surg"},{"key":"10.1016\/j.ejso.2026.111852_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104453","article-title":"CADONOT: comparing axillary dissection or not in breast cancer surgery","volume":"81","author":"Mattar","year":"2025","journal-title":"Breast"},{"issue":"8","key":"10.1016\/j.ejso.2026.111852_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2015.05.007","article-title":"Axillary lymph node dissection versus sentinel lymph node biopsy alone for early breast cancer with sentinel node metastasis: a meta-analysis","volume":"41","author":"Li","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111852_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-018-3021-9","article-title":"Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial","volume":"19","author":"Henke","year":"2018","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.ejso.2026.111852_bib34","doi-asserted-by":"crossref","DOI":"10.1097\/AS9.0000000000000159","article-title":"Omission of axillary staging and survival in elderly women with early stage breast cancer","volume":"3","author":"Castelo","year":"2022","journal-title":"Ann Surg Open"},{"key":"10.1016\/j.ejso.2026.111852_bib35","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-025-17196-x","article-title":"Downstream effects of omission of axillary surgery in older adults with early-stage HR+\/HER2\u2212 breast cancer","author":"Lorentzen","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111852_bib36","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-024-01816-7","article-title":"Selective omission of sentinel lymph node biopsy in mastectomy for ductal carcinoma in situ: identifying eligible candidates","volume":"26","author":"Bae","year":"2024","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.ejso.2026.111852_bib37","doi-asserted-by":"crossref","DOI":"10.1007\/s00268-008-9782-7","article-title":"Predictors of axillary lymph node metastases in breast cancer: is there a role for minimal axillary surgery?","volume":"33","author":"Yip","year":"2009","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.ejso.2026.111852_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.annonc.2024.10.015","article-title":"A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive\/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial","volume":"36","author":"Hortobagyi","year":"2025","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2026.111852_bib39","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.23.01994","volume":"42","author":"Rastogi","year":"2024","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2026.111852_bib40","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-015-4527-y","article-title":"Improving the accuracy of axillary lymph node surgery in breast cancer with ultrasound-guided wire localization of biopsy proven metastatic lymph nodes","volume":"22","author":"Plecha","year":"2015","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326004713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326004713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T23:01:43Z","timestamp":1779577303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326004713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0748798326004713"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111852","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted axillary dissection in the primary surgery setting for node-positive breast cancer: A systematic review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111852","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111852"}}